1. Home
  2. TCPC vs PGEN Comparison

TCPC vs PGEN Comparison

Compare TCPC & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCPC
  • PGEN
  • Stock Information
  • Founded
  • TCPC 2006
  • PGEN 1998
  • Country
  • TCPC United States
  • PGEN United States
  • Employees
  • TCPC N/A
  • PGEN N/A
  • Industry
  • TCPC Finance/Investors Services
  • PGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCPC Finance
  • PGEN Health Care
  • Exchange
  • TCPC Nasdaq
  • PGEN Nasdaq
  • Market Cap
  • TCPC 603.8M
  • PGEN 493.0M
  • IPO Year
  • TCPC 2012
  • PGEN N/A
  • Fundamental
  • Price
  • TCPC $5.83
  • PGEN $3.28
  • Analyst Decision
  • TCPC Sell
  • PGEN Buy
  • Analyst Count
  • TCPC 2
  • PGEN 5
  • Target Price
  • TCPC $6.75
  • PGEN $7.50
  • AVG Volume (30 Days)
  • TCPC 850.1K
  • PGEN 5.8M
  • Earning Date
  • TCPC 11-05-2025
  • PGEN 11-13-2025
  • Dividend Yield
  • TCPC 20.89%
  • PGEN N/A
  • EPS Growth
  • TCPC N/A
  • PGEN N/A
  • EPS
  • TCPC N/A
  • PGEN N/A
  • Revenue
  • TCPC $239,535,768.00
  • PGEN $4,340,000.00
  • Revenue This Year
  • TCPC N/A
  • PGEN $249.10
  • Revenue Next Year
  • TCPC N/A
  • PGEN $710.03
  • P/E Ratio
  • TCPC N/A
  • PGEN N/A
  • Revenue Growth
  • TCPC 3.11
  • PGEN N/A
  • 52 Week Low
  • TCPC $5.82
  • PGEN $0.65
  • 52 Week High
  • TCPC $9.72
  • PGEN $5.23
  • Technical
  • Relative Strength Index (RSI)
  • TCPC 21.24
  • PGEN 46.00
  • Support Level
  • TCPC $6.03
  • PGEN $3.37
  • Resistance Level
  • TCPC $6.17
  • PGEN $4.00
  • Average True Range (ATR)
  • TCPC 0.15
  • PGEN 0.25
  • MACD
  • TCPC -0.04
  • PGEN -0.12
  • Stochastic Oscillator
  • TCPC 0.00
  • PGEN 21.08

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: